Anacor Pharmaceuticals, Inc. et al v. Macleods Pharmaceuticals Ltd. et al.
| Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V. |
| Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. |
| 1:2021cv01350 |
| September 24, 2021 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 18, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorneys Elizabeth Chang, Dimitrios T. Drivas, John P. Scheibeler, Amit H. Thakore, and C. Sebastian Zonte for Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-cv-01348-CFC, 1:21-cv-01349-CFC, 1:21-cv-01350-CFC, 1:21-cv-01351-CFC, 1:21-cv-01353-CFC(srs) |
| Filing 15 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Macleods Pharma USA, Inc. for Macleods Pharmaceuticals Ltd. filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Seaman, John) |
| Filing 14 ANSWER to #1 Complaint, , COUNTERCLAIM against Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Seaman, John) |
| Filing 13 STIPULATION TO EXTEND TIME to Respond to Complaint to November 17, 2021 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Kirby, April) |
| Filing 12 NOTICE of Appearance by April M. Kirby on behalf of Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. (Kirby, April) |
| Filing 11 NOTICE of Appearance by John M. Seaman on behalf of Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. (Seaman, John) |
SO ORDERED, re #13 STIPULATION TO EXTEND TIME to Respond to Complaint to November 17, 2021 filed by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc. Set/Reset Answer Deadlines: Macleods Pharma USA, Inc. answer due 11/17/2021; Macleods Pharmaceuticals Ltd. answer due 11/17/2021. Ordered by Judge Colm F. Connolly on 10/18/2021. (kmd)
|
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, Amit H. Thakore, C. Sebastian Zonte and Elizabeth Chang - filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V.. (Dellinger, Megan) |
|
SO ORDERED, re (9 in 1:21-cv-01349-CFC, 12 in 1:21-cv-01348-CFC, 10 in 1:21-cv-01353-CFC, 10 in 1:21-cv-01351-CFC, 10 in 1:21-cv-01350-CFC) MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, Amit H. Thakore, C. Sebastian Zonte and Elizabeth Chang filed by PF PRISM IMB B.V., Anacor Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 10/14/2021. Associated Cases: 1:21-cv-01348-CFC, 1:21-cv-01349-CFC, 1:21-cv-01350-CFC, 1:21-cv-01351-CFC, 1:21-cv-01353-CFC (kmd)
|
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:21-cv-01348-CFC, 1:21-cv-01349-CFC, 1:21-cv-01350-CFC, 1:21-cv-01351-CFC, 1:21-cv-01353-CFC (rjb) |
| Filing 9 AFFIDAVIT of Service for Summons, Complaint and related papers served on Macleods Pharmaceuticals Ltd. on September 28, 2021, filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V.. (Dellinger, Megan) |
| Filing 8 SUMMONS Returned Executed by PF PRISM IMB B.V., Anacor Pharmaceuticals, Inc.. Macleods Pharma USA, Inc. served on 9/27/2021, answer due 10/18/2021. (Blumenfeld, Jack) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. and Corporate Parent PF Prism C.V. for PF PRISM IMB B.V.; Corporate Parent Pfizer Inc. for Anacor Pharmaceuticals, Inc. filed by Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.. (srs) |
| Filing 7 Summons Issued with Magistrate Consent Notice attached as to Macleods Pharma USA, Inc. on 9/24/2021. (srs) |
| Filing 6 Summons Issued with Magistrate Consent Notice attached as to Macleods Pharmaceuticals Ltd. on 9/24/2021. (srs) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,039,451 B2 ; 8,168,614 B2 ; 8,501,712 B2 ; 9,682,092 B2. (srs) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/17/2021. Date of Expiration of Patent: See ANDA Form.Thirty Month Stay Deadline: 12/14/2024. (srs) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Filing 1 COMPLAINT filed against Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3707110.) - filed by PF PRISM IMB B.V. and Anacor Pharmaceuticals, Inc. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet)(srs) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
